
    
      Almonertinib Alone Versus Almonertinib Plus Chemotherapy as First-line Treatment in Patients
      With Epidermal Growth Factor Receptor (EGFR) Mutation Positive With Concomitant Non-EGFR
      Driver Gene Mutation Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A
      Multicenter, Open-label, Randomized, Control Phase III Study (ACROSS 1).
    
  